A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Royal North Shore Hospital Department of Endocrinology, St Leonards

Universita di Torino, Orbassano

Charite Universitaetsmedizin, Berlin

Duke Clinical Cancer Trials Services, Durham

University of Miami, Miami

Ohio State University, Columbus

Karmanos Cancer Institute, Detroit

Centre Léon Bérard, Lyon

Mary Crowley Cancer Research Center, Dallas

MD Anderson Cancer Center, Houston

University of Colorado Denver Cancer Center, Aurora

LMU München, Munich

TGen Clinical Research Service at Scottsdale Healthcare, Scottsdale

University of Southern California, Los Angeles

UCLA, Los Angeles

Universitaets Klinikum Wuerzburg, Würzburg

Dana-Farber Cancer Institute, Boston

University of Michigan, Ann Arbor

Dartmouth Medical School, Lebanon

Vanderbilt University Medical Center, Nashville

St. Joseph's Hospital, Hamilton

PMH - Princess Margaret Hospital, Toronto

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

CHRU Lille, Clinique Endocrinologique Marc Linquette, Lille

Institut Paoli-Calmettes, Marseille

Hôpital Cochin-Saint Vincent de Paul, Paris

CHU Bordeaux - Hôpital Haut-Lévêque, Pessac

Institut Gustave Roussy, Villejuif

Università Cattolica del Sacro Cuore, Rome

Academic Medical Center, Amsterdam

Maxima Medisch Centrum (MMC), Eindhoven

Erasmus MC Rotterdam, Rotterdam

Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie Oddzial w Gliwicach, Gliwice

St. James' University hospital, Leeds

Royal Marsden NHS Trust, London